logo-loader
RNS
Metir PLC

Metir PLC - Trading Statement

RNS Number : 6056O
Metir PLC
13 January 2026
 

 

13 January 2026

                                                                                                                                                                          

Metir plc

 

("Metir", the "Group" or the "Company")

 

Trading Update

 

Metir plc (AIM: MET), the leading global provider of fast-response, mobile and point-of-use water and environmental monitoring technologies, is pleased to provide a trading update for the financial year ended 31 December 2025 ("FY25"). The Group's Annual Report and Accounts are expected to be published in May 2026.

 

Trading in FY25 was in line with management expectations, with growth driven by increased international demand for Microtox® LX instruments, Microtox® reagents and Sulphate Reducing Bacteria ("SRB") kits, alongside continued progress in large-scale potable water monitoring projects with the Continuous Toxic Monitoring ("CTM") installation in Qatar. The Group expects to report revenues of £1.5m (31 December 2024: £0.23m) and a cash balance at the year-end of £1.04m following the successful fundraise of £1.0m, before expenses, completed on 22 December 2025.

 

The Group has continued to build on the momentum reported in its interim results announced on 30 September 2025 and the trading update released on 2 December 2025. Customer demand for Microtox® LX instruments remained strong throughout the second half of the year. Although outsourced manufacturing output increased during H2 2025, production capacity was limited during Q4 2025, constraining the pace at which customer demand could be converted into revenue. Due to these restrictions, 10 of the 56 Microtox® LX instruments ordered in FY25 could not be fulfilled; however, they are now being manufactured and will be delivered in early 2026. Increasing the outsourced manufacturing capacity of Microtox® FX instruments is a key near-term objective in 2026 following increased sales interest.

 

The growing installed base of Microtox® LX and FX instruments is expected to drive demand for high-margin Microtox® reagents. The Board believes that unlocking this high-margin recurring revenue stream is a significant financial objective for the business, with a focus on not only increasing manufacturing capacity, but also working with customers to drive greater reagent usage.

 

Demand for SRB kits, which were relaunched in June 2025, remained robust. Customer interest increased materially, with quotations provided to more than 60 companies worldwide. During Q4 2025, production of SRB kits was temporarily paused due to a manufacturing quality control assessment. The objective is to restart production as soon as practicable, possibly using an alternative biological component to ensure Modern Water's QuickChek™ SRB kit remains the market-leading fast response product.

 

Throughout FY25, the Board continued to prioritise investment in scaling-up manufacturing, product development and commercial capability, consistent with the Group's strategy to build a growing recurring-revenue business for its current product range. In addition, Metir is developing what it believes could be significant future revenue streams from new technologies, including its proprietary mobile PFAS testing technology with Swansea University, and progressing towards completion of the Cryptosporidium project in 2026 with Aptamer Group plc for deployment of a commercial real-time continuous Pathogen Detector.

 

The Group completed a fundraising in December 2025 to strengthen working capital, accelerate manufacturing output and therefore support the conversion of a growing order book into revenue. The Board believes this additional funding materially improves the Group's ability to execute its near-term growth plans and to increase margins on its products.

 

Metir has growing revenues from multiple and diverse Modern Water product streams. Ongoing development of the Group's unique mobile PFAS detection and Pathogen Detection technologies will increase the product portfolio further.

 

Bob Moore, Executive Chairman and Chief Executive Officer of Metir plc, commented:

 

"FY25 marked a year of strong commercial progress for Metir, with customer demand continuing to grow across Modern Water's instrument, reagent and testing kit portfolio. While manufacturing capacity constrained the Group's ability to fully meet demand during the year, the underlying momentum in the business is encouraging for sales growth throughout 2026.

 

"With enhanced funding in place, a growing installed base of instruments and an expanding international pipeline, we enter this year with increased confidence. The Board believes the actions taken during FY25, including further product development, provide a solid foundation for accelerating production of the Group's instrumentation and reagents, driving revenue growth and progressing towards sustainable profitability.

 

"We look forward to reporting progress on the Group's growth initiatives over the coming months."

 

-      Ends -

 

Enquiries:

 

Metir plc

Bob Moore, Executive Chairman and Chief Executive Officer

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets
(Nominated Adviser & Joint Broker)

Alex Bond

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited
(Joint Broker)

Andrew Thacker / Guy McDougall 

+44 (0) 20 3657 0050

 

Northstar Communications (Investor Relations)

Sarah Hollins

+44 (0) 113 730 3896

 

About Metir

 

Metir plc is a leading global provider of several fast-response, mobile and point-of-use water and environmental monitoring technologies. Through its two established trading divisions, Modern Water and Microsaic Systems, a specialist in mobile PFAS monitoring, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water and liquids quality results, helping industries, utilities and regulators monitor safety and compliance in real time.

 

With a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.

 

Headquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.

 

For more information, please visit: https://www.metirplc.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXGDBGSBDGLD
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

1 week, 2 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 6 days ago

5 min read